Navigation Links
Cancer Care Compromised by Cost

A team of researchers has recommended that, in order to implement better cancer care to patients certain reforms have to be mustered immediately. //Their views were published in the British Medical journal. The team of researchers opined that the National Institute for Health and Clinical Excellence (NICE) should amend some of their modes of action, in order to cater to the immediate needs of cancer patients. More planning is essential to ensure that those battling with cancer shall be assured supply of life saving drugs through the NHS.

Last August NICE, had pointed that unless local Trusts mobilized funds, they would be unable to cover the entire costs of drugs like Herceptin to patients. Herceptin is a drug that can fight cancer by targeting a protein, the HER2 protein, which can trigger off tumors. Almost 20% of breast cancers are noted to be HER2 positive. NICE has ruled that, all breast cancer patients that are HER2 would benefit from treatment with Herpecitin following chemotherapy, surgery or radiation therapy. However following this ruling, no move has been made by NICE to indicate where the extra funds should be recovered from. Unless federal funds are released, cancer patient who cannot afford the treatment cannot get the benefits.

Doctors from Norwich University Hospital NHS Trust studied the data linked to the bulk of cancer patients receiving treatment at their hospital. Their findings show that 1.9 million pounds are required to make the drug Herpecitin available to all patients who need the drug. Costs cannot be contained with the treatment alone. The projected expense can be covered only if the equally important palliative care or chemotherapy is done away with, they concluded.

There is no conclusive data that shows that there are any long term benefits that the drug Herpecetin, promises except that it is the drug of choice at this moment. That is not a reliable reason to deny patients conventional treatment and sw itch over to Herpecitin, which is not cost effective either, say doctors.

Doctors who were part of the study opine that, in an ideal situation the government should back up their decision by providing the source of funding for newer drugs. Suggestions have been framed, urging the Department of Health to keep aside money to fund NICE.
MST
'"/>




Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Consensus on "Combination Therapy" for Breast Cancer
6. Cancers of Colon & Rectum linked to Cigarette Smoking
7. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
8. The Cancer Rumour mill working over time
9. Cancer drugs in development nearly doubled since 1995
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. Cancer patients turning to Internet for information
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/8/2016)... KS (PRWEB) , ... February 08, 2016 , ... TopConsumerReviews.com ... leader in Mole removal products. , Moles are derived from a cluster of melanin ... in all the wrong places and create a lifetime of embarrassment. Historically, mole ...
(Date:2/8/2016)... ... 08, 2016 , ... According to research by the National ... technicians to be certified or obtain continuing education. To increase patient awareness of ... Your Mouth?” campaign to inform dentists and patients about the possible lack of ...
(Date:2/7/2016)... ... February 07, 2016 , ... ... Plastics, has added Kybella® to his medical and surgical expertise. Technically known as ... FDA injectable medication used as a non-surgical alternative for reduction of fat below ...
(Date:2/6/2016)... St. Petersburg, FL (PRWEB) , ... February 06, 2016 , ... ... AsSeenOnTV.pro are pleased to announce the launch of a new DRTV campaign with Belly ... rug. If having tried everything from sprays to puppy pads and find nothing works, ...
(Date:2/5/2016)... ... 05, 2016 , ... VeloReality President and co-founder ... LYNX VR Indoor Trainer with multi-rider capability to an enthusiastic audience at the ... reduce the weight of the unit, they also enhance the rider's experience with ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... 4, 2016  The Senior Care Pharmacy Coalition ... Committee Chairman Jason Chaffetz (R-UT) and ... hearing , "Developments in the Prescription Drug ... growing questions about abusive pharmacy benefit manager (PBM) ... and Ranking Member Elijah Cummings (D-MD) are diligent, ...
(Date:2/4/2016)... , Feb. 4, 2016   Bernstein Liebhard LLP ... in the United States District Court for the District of ... (the "Class") consisting of all persons or entities who purchased ... (NASDAQ: INSY ) from March 3, 2015 through January ... certain of its officers with violations of the Securities Exchange ...
(Date:2/4/2016)... LONDON , Feb. 4, 2016 ... Summary Global Markets Direct,s, ,Wegener Polyangiitis - ... the Wegener Polyangiitis,s therapeutic pipeline. This report ... Wegener Polyangiitis, complete with comparative analysis at various ... action (MoA), route of administration (RoA) and molecule ...
Breaking Medicine Technology: